Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
17 October 2018Website:
http://si-bone.comNext earnings report:
07 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 21 Jun 2024 22:13:03 GMTDividend
Analysts recommendations
Institutional Ownership
SIBN Latest News
SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2024 Truist Securities MedTech Conference in Boston. Management will be hosting a fireside chat on Tuesday, June 18, at 3:40 p.m. Eastern Time / 12:40 p.m. Pacific Time.
Si-Bone reported a quarterly loss of $0.27 per share, which was better than the expected loss of $0.29 per share according to Zacks. This is an improvement from the loss of $0.32 per share reported in the same quarter last year.
Si-Bone (SIBN) has the perfect mix of factors that suggest it may beat earnings expectations in its upcoming report. Make sure you are ready with the important predictions.
SI-BONE, Inc. (Nasdaq: SIBN), a company focused on treating musculoskeletal disorders of the sacropelvic anatomy, will be attending the 2024 BofA Securities Healthcare Conference in Las Vegas. The company's management will be holding a fireside chat on Tuesday, May 14, at 2:20 p.m. Eastern Time / 11:20 a.m. Pacific Time.
SI-BONE, Inc., a medical device company focused on addressing sacropelvic anatomy disorders, will release its financial results for the first quarter of 2024 after the market closes on May 6, 2024. A conference call led by management will follow at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Barclays 26th Annual Global Healthcare Conference in Miami. Management will be hosting a fireside chat on Tuesday, March 12, at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time.
Si-Bone (SIBN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SANTA CLARA, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Monday, February 26, 2024. Management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Piper Sandler Healthcare Conference in New York. Management will be hosting a fireside chat on Tuesday, November 28, 2023, at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time.
SI-BONE, Inc. (NASDAQ:SIBN ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Saqib Iqbal - Senior Director of IR Laura Francis - CEO Anshul Maheshwari - CFO Conference Call Participants Young Li - Jefferies Drew Ranieri - Morgan Stanley Craig Bijou - Bank of America David Saxon - Needham & Company Dave Turkaly - JMP Securities Caitlin Cronin - Canaccord Samuel Brodovsky - Truist Securities Operator Good afternoon and welcome to SI-BONE's Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 1(current)
What type of business is SI-BONE?
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
What sector is SI-BONE in?
SI-BONE is in the Healthcare sector
What industry is SI-BONE in?
SI-BONE is in the Medical Devices industry
What country is SI-BONE from?
SI-BONE is headquartered in United States
When did SI-BONE go public?
SI-BONE initial public offering (IPO) was on 17 October 2018
What is SI-BONE website?
https://si-bone.com
Is SI-BONE in the S&P 500?
No, SI-BONE is not included in the S&P 500 index
Is SI-BONE in the NASDAQ 100?
No, SI-BONE is not included in the NASDAQ 100 index
Is SI-BONE in the Dow Jones?
No, SI-BONE is not included in the Dow Jones index
When does SI-BONE report earnings?
The next expected earnings date for SI-BONE is 07 August 2024